Low Leverage / Clean Balance SheetMinimal reported debt and low leverage materially reduce solvency risk and give management flexibility to fund R&D or endure further operating losses without immediate refinancing. This durable cushion supports strategic options and extends runway compared with highly levered peers.

Accelerating Revenue GrowthSustained acceleration in revenue over recent annual periods indicates improving commercial traction and market adoption of core offerings. Durable top-line growth is a prerequisite for future operating leverage and eventual profitability if cost structure normalizes.

Specialized X‑ray Tech In Medical DevicesOperating in medical devices with a focused X‑ray technology offers structural demand and potential differentiation. Specialized clinical equipment typically faces higher barriers to entry and long product lifecycles, supporting durable revenue visibility once clinical adoption and regulatory clearance scale.

Bears Say

Persistent Operating LossesConsistent, sizable operating losses erode equity and constrain reinvestment capacity. Over a multi‑month horizon, sustained losses limit ability to self‑fund expansion, increase dependence on capital raises, and delay the point at which revenue growth converts into durable profitability.

Material Negative Operating Cash FlowRepeated negative operating and free cash flow signal ongoing cash burn and likely reliance on external financing. This structural cash deficit elevates dilution or liquidity risk, constraining long‑term investment and making strategic execution dependent on successful fundraising.

Volatile And Negative MarginsNegative and inconsistent gross and operating margins indicate issues with pricing, cost control, or product mix that impede scalability. Without sustained margin improvement, revenue growth alone will not translate to profitable operations, prolonging the path to positive returns.

LUR FAQ

What was Luxbright AB’s price range in the past 12 months?

Luxbright AB lowest stock price was €0.02 and its highest was €0.07 in the past 12 months.

What is Luxbright AB’s market cap?

Luxbright AB’s market cap is €4.29M.

When is Luxbright AB’s upcoming earnings report date?

Luxbright AB’s upcoming earnings report date is Aug 14, 2026 which is in 158 days.

How were Luxbright AB’s earnings last quarter?

Luxbright AB released its earnings results on Jan 30, 2026. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.

Is Luxbright AB overvalued?

According to Wall Street analysts Luxbright AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luxbright AB pay dividends?

Luxbright AB does not currently pay dividends.

What is Luxbright AB’s EPS estimate?

Luxbright AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Luxbright AB have?

Luxbright AB has 130,148,010 shares outstanding.

What happened to Luxbright AB’s price movement after its last earnings report?

Luxbright AB reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.905%.

Which hedge fund is a major shareholder of Luxbright AB?

Currently, no hedge funds are holding shares in DE:LUR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Luxbright AB

Luxbright AB (publ), a technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. The company was incorporated in 2012 and is headquartered in Gothenburg, Sweden.